We only have this paper's title and publication details.
Read it at the sourceAnalysis reveals characteristics in advanced high-grade serous tubo-ovarian cancer survivors, highlighting cohort distinctions.
Table S4 displays the characteristics and subtypes of the Charité cohort.
No takes yet. Share an insight, caveat, or question.
Marchenko et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: